What Causes Male Pattern Baldness? A Guide to Androgenetic Alopecia

Understanding the science behind male pattern baldness is the first step towards managing it. Known in clinical terms as androgenetic alopecia, this common type of hair loss is not caused by external factors like wearing hats or using certain shampoos. The primary causes are a combination of genetics and the body's response to specific hormones.

It is a gradual process that follows a predictable pattern, driven by internal biological factors.

The Science of Androgenetic Alopecia Explained

Male pattern baldness is the most common form of hair loss affecting men. In the UK, it is estimated to affect around 85% of men by the age of 50 and accounts for over 95% of all male hair loss cases.

Given its prevalence, understanding the underlying biological mechanism is essential for anyone considering how to manage it. This guide provides a clear, evidence-based overview of the core science, covering:

• The role of family history and genetics.
• The specific hormone, DHT, that triggers hair follicle miniaturisation.
• The disruption of the natural hair growth cycle.
• How a clinician provides a formal diagnosis in the UK.

The Three Pillars of Male Pattern Baldness

Male pattern baldness can be understood through three key components. Firstly, your genetics determine the sensitivity of your hair follicles to hormones. Secondly, the hormone DHT acts as a trigger, initiating a process called ‘miniaturisation’. Finally, this hormonal action disrupts the hair growth cycle, leading to the visible hair thinning observed over time.

Male pattern baldness is a natural, genetically determined condition, not a disease. It occurs when hair follicles have an inherited sensitivity to normal levels of androgens; it is not typically caused by abnormally high testosterone levels.

Let’s summarise these key contributors.

Key Factors in Male Pattern Baldness at a Glance

This table breaks down the primary scientific factors that drive androgenetic alopecia, providing a clear overview of how they interact.

Understanding these pillars helps to demystify the process.

Grasping the fundamentals of what causes male pattern baldness is crucial before exploring treatment options. The most effective options are often prescription-only medications, which require a clinical assessment to ensure they are a safe and suitable choice for the individual.

A UK-registered pharmacy can facilitate a confidential consultation with a qualified clinician, allowing patients to discuss their hair loss and explore MHRA-approved, prescription-only treatments from home.

Cracking the Genetic Code of Hair Loss

While hormones are the active trigger for hair loss, genetics provide the underlying predisposition. DNA contains the instructions that dictate how hair follicles behave. At its core, androgenetic alopecia is a hereditary condition. The likelihood of experiencing it, the age of onset, and the pattern of hair loss are all heavily influenced by genes passed down through your family.

This genetic component explains why one individual may have high levels of dihydrotestosterone (DHT) and maintain a full head of hair, while another with lower levels experiences significant thinning. It is not solely the presence of the hormone but the follicle's genetically programmed sensitivity to it.

Is It Really All From Your Mum's Side?

A common belief is that hair loss is inherited from the maternal grandfather. There is a scientific basis for this, but it is not the complete picture. The primary gene associated with male pattern baldness, the Androgen Receptor (AR) gene, is located on the X chromosome.

Men inherit their X chromosome from their mother and their Y chromosome from their father. This means the sensitivity of hair follicles to androgens is strongly linked to the maternal line. Therefore, observing a maternal grandfather’s hairline may offer an indication.

However, modern research shows the situation is more complex.

It Takes Two: Genes from Both Parents

Researchers have now identified numerous other genes on different chromosomes that also contribute to androgenetic alopecia. These can be inherited from either the mother or the father. This makes hair loss a polygenic trait—one influenced by multiple genes acting in concert.

This is why an individual's pattern of balding may not exactly mirror that of a single relative. It is a combination of genetic instructions from both parents.

An individual's unique genetic profile is a combination of DNA from both parents. While the X chromosome plays a significant role, it works alongside many other genetic markers to determine the overall risk of hair loss.

Due to this complex genetic inheritance, it is not possible to predict the future of your hair with absolute certainty by examining your family tree.

The Androgen Receptor Gene's Starring Role

The primary function of the Androgen Receptor (AR) gene is to provide instructions for building androgen receptors on cells throughout the body, including hair follicles. These receptors are the binding sites for androgens like testosterone and DHT.

If an individual inherits a specific variant of the AR gene, their follicles produce receptors that are particularly effective at binding to DHT. This heightened sensitivity is what initiates the hair loss process.

• Genetic Sensitivity: Your DNA dictates how "receptive" your hair follicles are to DHT.
• Hormonal Action: DHT, a potent by-product of testosterone, circulates in the bloodstream.
• Follicle Shrinkage: When DHT binds to these highly sensitive receptors, it signals the follicle to begin shrinking in a process known as miniaturisation.

The inheritance of male pattern baldness in the UK often follows these family lines, with hair loss sometimes appearing to skip a generation and pass down through the mother's side. You can explore more about UK-specific hair loss trends and the X chromosome connection to understand this pattern better.

Ultimately, your genetic makeup is the root cause, laying the groundwork for how your follicles respond to normal hormonal changes. This is why addressing hair loss effectively often requires professional medical advice. A consultation through a UK-registered pharmacy is a sensible first step to determine if a prescription-only treatment is appropriate for you.

How DHT Makes Hair Follicles Shrink

While genes create the predisposition for male pattern baldness, the hormone dihydrotestosterone (DHT) is the direct trigger. The issue is not an excess of testosterone but rather how genetically-primed hair follicles overreact to normal levels of DHT.

The process begins with an enzyme called 5-alpha reductase, which is present in the skin, prostate, and hair follicles. This enzyme converts testosterone into the more potent androgen, DHT.

This conversion is a natural physiological process in all men. In those without a genetic predisposition to hair loss, it does not affect scalp hair. However, for those with the genetic sensitivity, this is where the process of hair loss is initiated.

The Lock and Key Effect

Once produced, DHT circulates in the bloodstream and binds to specific sites on hair follicles called androgen receptors. This can be compared to a lock and key mechanism:

• The Key: Dihydrotestosterone (DHT).
• The Lock: The androgen receptor on the hair follicle.

In men with androgenetic alopecia, the androgen receptors on their scalp follicles are genetically programmed for high sensitivity. When DHT (the key) binds to this sensitive receptor (the lock), it initiates a process of progressive follicle miniaturisation.

This is the central mechanism of male pattern baldness. It is a gradual shrinking of the hair follicle that undermines its ability to produce a healthy, strong hair.

As the image below illustrates, this genetic sensitivity is often inherited via the X chromosome from the mother, which is why observing the maternal grandfather's hair can be an indicator of hair loss risk.

While genes from both parents contribute, this highlights the significant influence of the maternal genetic line.

The Slow Shrink: How Miniaturisation Works

Miniaturisation is a slow, progressive cycle. With each new hair that grows from an affected follicle, it is weaker and finer than its predecessor. The follicle itself shrinks slightly with every hair growth cycle.

This gradual weakening leads to the visible changes associated with hair loss.

The core issue in male pattern baldness is not the immediate loss of hair, but a change in its character. Hairs become shorter, finer, and lighter in colour, until the follicle can no longer produce a visible hair.

As the follicle continues to shrink, the hair it produces is significantly altered:

1. It gets thinner: The diameter of the hair shaft reduces, making each strand finer and weaker.
2. It gets shorter: The growth phase (anagen phase) of the hair cycle is truncated, preventing hairs from reaching their previous length.
3. It gets lighter: These miniaturised hairs often lose pigmentation, eventually resembling the fine, near-invisible "vellus" hairs.

Eventually, the follicle shrinks to a point where it becomes dormant and ceases hair production entirely. This creates the classic patterns of thinning and baldness.

How Clinically Proven Treatments Target the Cause

Understanding the DHT mechanism is vital because it is the process that clinically proven, MHRA-approved treatments are designed to interrupt. The most effective prescription-only treatments work by inhibiting the 5-alpha reductase enzyme. By blocking this enzyme, they reduce the conversion of testosterone to DHT.

By lowering DHT levels in the scalp, these prescribed medications can help to slow, stop, or in some cases partially reverse the miniaturisation process, allowing damaged follicles to recover and produce thicker, healthier hair.

As these are potent prescribed medications, an assessment from a qualified clinician is required to ensure they are a safe and appropriate option. A UK-registered pharmacy, regulated by the GPhC, provides a secure way to obtain this assessment and, if suitable, a prescription.

How Hair Loss Disrupts Your Natural Growth Cycle

To understand male pattern baldness, it is helpful to first understand how healthy hair grows. Each hair on the scalp independently follows a three-part cycle. This staggered timing ensures a consistent head of hair, preventing mass shedding.

This regenerative process is a finely tuned biological mechanism. DHT disrupts this cycle, leading to the progressive thinning seen in androgenetic alopecia.

The Three Phases of Healthy Hair Growth

Every hair follicle cycles through three distinct stages over several years. Understanding these stages clarifies how DHT causes damage.

1. Anagen (The Growth Phase): Lasting for 2 to 7 years, this is the active phase where cells in the hair root divide to build a new hair strand. This long phase determines the maximum length of the hair.

2. Catagen (The Transition Phase): A brief phase of about 2 to 3 weeks where growth stops and the follicle shrinks, detaching from its blood supply.

3. Telogen (The Resting Phase): Lasting for about 3 to 4 months, the old hair rests in the follicle while a new hair begins to grow beneath it. The old hair is eventually shed as the new hair emerges, restarting the anagen phase.

On a healthy scalp, approximately 85-90% of hairs are in the anagen phase at any time, creating the appearance of a full head of hair.

How DHT Derails the Cycle

In men with a genetic sensitivity, DHT disrupts this orderly cycle. It shortens the anagen (growth) phase and can prolong the telogen (resting) phase.

The most significant impact is the shortening of the anagen phase. A follicle that was programmed to grow hair for years may now only do so for a few months. This gives the hair less time to mature, resulting in a shorter, weaker, and finer hair with each new cycle.

Simultaneously, DHT can extend the telogen phase. This means that after a hair is shed, the follicle remains dormant for longer before a new one starts to grow. This leads to more follicles being inactive at any given time, contributing to a loss of overall hair density.

In androgenetic alopecia, the hair growth cycle is fundamentally altered. The growth phase becomes shorter, while the resting phase becomes longer. This imbalance is the direct cause of progressive thinning and reduced hair density.

The Visible Outcome: A Side-by-Side Comparison

These changes explain why male pattern baldness occurs gradually. It is a slow, progressive shift in the hair cycle, not a sudden event.

This table breaks down the difference between a healthy cycle and one affected by DHT.

This process of miniaturisation is the essence of male pattern baldness. With each cycle, the hair becomes finer and the follicle spends more time resting, until it can no longer produce a visible hair.

Understanding this mechanism is important, as it is what modern treatments are designed to address. Many MHRA-approved options work by counteracting DHT's influence, helping to restore a healthier anagen phase duration and protect follicles from miniaturisation. Since many of these treatments are prescription-only, a consultation with a clinician via a regulated service, such as a UK-registered pharmacy, is required for access.

Receiving a Clinical Diagnosis for Hair Loss

While understanding the science of male pattern baldness is useful, self-diagnosis is not recommended. A formal diagnosis from a clinician is a crucial first step, particularly before considering any prescription-only treatment.

Diagnosing androgenetic alopecia is typically straightforward and does not usually require extensive testing. In most cases, a clinician can make a confident diagnosis during a single consultation, whether in-person or through a regulated online service. The primary goals are to confirm the diagnosis of male pattern baldness and rule out other potential causes.

The Consultation Process

A clinician will begin by taking a medical and family history. They will ask about the onset and progression of the hair thinning and whether any close relatives have experienced similar hair loss. This information helps to establish a pattern and suggest a potential genetic link.

Next, a physical examination of the scalp is performed. An experienced clinician will assess the specific pattern of hair loss, as this is a key diagnostic feature of androgenetic alopecia. They will look for the characteristic signs of a receding hairline or thinning at the crown (vertex).

A clinical diagnosis of male pattern baldness is largely based on pattern recognition. The condition follows a predictable progression, which experienced clinicians can identify through visual examination.

Using the Norwood Scale

To classify the extent of hair loss, clinicians often use the Norwood Scale. This is a standardised classification system that outlines seven stages of male pattern baldness, from a full head of hair (Stage 1) to extensive baldness across the top of the scalp (Stage 7).

The scale is useful for several reasons:

• It provides an objective assessment of the current stage of hair loss.
• It serves as a baseline to track future changes.
• It helps in setting realistic expectations for treatment outcomes.

The scale provides a common language for both the clinician and the patient to discuss the condition.

Ruling Out Other Causes of Hair Loss

A thorough diagnosis involves excluding other potential causes of hair loss. While male pattern baldness accounts for over 95% of hair loss in men, other conditions can sometimes present similarly.

A clinician will consider other possibilities, such as:

• Alopecia Areata: An autoimmune condition causing distinct, patchy hair loss.
• Telogen Effluvium: A temporary, diffuse shedding of hair, often triggered by significant stress, illness, or nutritional deficiencies.
• Traction Alopecia: Hair loss caused by persistent tension on the hair from tight hairstyles.
• Underlying Health Conditions: In rare cases, conditions like thyroid disorders or scalp infections can cause hair thinning.

If the pattern of hair loss is atypical or accompanied by other unusual symptoms, the clinician may recommend blood tests to check for nutrient deficiencies or hormonal imbalances. However, for most men, a clinical history and scalp examination are sufficient to confirm the diagnosis.

Obtaining this clinical confirmation is essential. It ensures that the correct condition is being treated with a safe, effective, and regulated approach. A UK-registered online pharmacy, regulated by the GPhC, offers a secure and private way to complete this necessary step. You can find out more in our guide to getting a UK online doctor consultation.

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any treatment.

A Look at Managing Hair Loss in the UK

Once the biological process of hair loss—the interaction between genetics and DHT—is understood, the rationale behind modern treatments becomes clear. In the UK, the most effective, clinically-proven approaches intervene directly in this biological pathway. They are medical treatments targeting the hormonal and cellular triggers of hair loss.

The primary objectives of an evidence-based management plan are to slow or halt further thinning and, where possible, encourage some regrowth. This is typically achieved through long-term management strategies that require medical supervision.

How Proven Treatments Get to the Root of the Problem

The main strategies for managing androgenetic alopecia in the UK fall into two categories, each with a distinct mechanism of action.

• Blocking the Hormone: A common approach is to reduce the amount of DHT that can affect hair follicles. This is achieved with oral medications that inhibit the 5-alpha reductase enzyme, thereby reducing DHT levels in the scalp. By mitigating the hormonal trigger, these treatments help to protect follicles from further miniaturisation.

• Stimulating the Follicle: Another major approach involves a topical treatment applied directly to the scalp. This type of medication works as a vasodilator, widening blood vessels to improve blood flow and nutrient delivery to the hair roots. It also helps to prolong the hair's anagen (growth) phase, improving the potential for follicles to produce thicker, longer hairs.

It is important to understand that the most effective options are MHRA-approved, prescription-only treatments. This regulatory control is a safety measure to ensure that a qualified clinician assesses a patient's medical history and suitability before any medication is prescribed.

Managing male pattern baldness is focused on effective, long-term control rather than a complete reversal. Clinically proven treatments are designed to slow the progression, preserve existing hair, and potentially restore some lost density.

Why a Regulated Clinical Route is Essential

As these treatments are medicines, obtaining them through a safe and legal route is paramount. Self-diagnosis or purchasing from unregulated websites poses a risk to health. The correct pathway in the UK always begins with a consultation with a healthcare professional, which can be conducted through a UK-registered pharmacy.

This regulated process includes several important safety checks:

• A prescriber confirms the diagnosis of male pattern baldness.
• They review the patient's overall health and any other medications to check for potential contraindications.
• The patient receives clear information about the benefits, limitations, and potential side effects.

This clinical oversight is a legal requirement and is fundamental to patient safety. Services regulated by the GPhC (General Pharmaceutical Council) adhere to strict standards, providing a secure and reliable way to explore appropriate treatment options. You can learn more about how a regulated online pharmacy in the UK operates to ensure patient safety.

While exploring options, surgical Hair Restoration may also be considered. For many men, however, the initial approach involves clinically proven, prescribed medication to stabilise hair loss non-surgically. Beginning with a professional consultation is the most sensible first step.

Frequently Asked Questions

This section addresses some of the most common questions and misconceptions about what causes male pattern baldness.

Does Wearing a Hat Cause Male Pattern Baldness?

No. This is a persistent myth. Male pattern baldness is caused by internal genetic and hormonal factors. External actions such as wearing a hat, using styling products, or shampooing frequency do not cause this specific type of hair loss. The cause is the inherited sensitivity of hair follicles to DHT.

Am I Safe from Baldness if My Dad Has a Full Head of Hair?

Not necessarily. The genetics of hair loss are complex and involve contributions from both sides of the family. The most significant gene for baldness is located on the X chromosome, which is inherited from the mother. Therefore, observing the maternal grandfather's hairline can be a useful indicator. However, dozens of other genes from both parents also play a role, so a father with a full head of hair does not guarantee the same for his son.

The inheritance of hair loss is polygenic, meaning it involves multiple genes. This is why you may experience a different pattern of hair loss—or none at all—compared to your father or brothers.

Can Stress or My Diet Trigger Male Pattern Baldness?

While severe stress or significant nutritional deficiencies can cause a temporary, diffuse hair shedding known as telogen effluvium, they do not cause male pattern baldness itself. Androgenetic alopecia is a distinct, genetically predetermined process. However, maintaining a balanced diet and managing stress is beneficial for overall hair health and can support the effectiveness of any treatments.

Is There a Cure for Male Pattern Baldness?

Currently, there is no "cure" that can permanently alter the genetic predisposition for male pattern baldness. However, several MHRA-approved, prescription-only treatments are available in the UK that are clinically proven to manage the condition effectively. These treatments can slow progression, prevent further loss, and, for many men, stimulate some regrowth. The modern approach focuses on long-term management. Accessing these treatments requires a consultation with a healthcare professional to ensure they are a safe and appropriate option for you. You can learn more about clinically proven hair loss treatments that are available following a clinical assessment.

At XO Medical, we offer a safe, regulated, and straightforward way to manage your hair loss. Our UK-registered clinicians provide confidential online consultations to assess your situation and, where appropriate, prescribe MHRA-approved treatments delivered discreetly to your home. Begin your free online consultation today.